Wpływ soi i izoflawonów sojowych na tarczycę

1. Jabłoński E.: Soja i jej przetwory alternatywnym czy niekonwencjonalnym źródłem pożywienia. Kwart. Biul. Pol. Tow. Diet. 1999, 14, 21. 2. Łyszkowska M.: Znaczenie soi w żywieniu. Przegl. Pediatr. 1999, 29, 306. 3. Garcia M.C, Torze M., Marina M.L. i wsp.: Composition and characterization of soyabean and related products. Crit. Rev. Food Sci. Nutr. 1977, 37, 361. 4. Krauze-Brzósko K., Brzósko S., Rotondo S. i wsp.: Fitoestrogeny soi i ich znaczenie dla zdrowia człowieka. Pol. Merkuriusz Lek. 2002, 13, 526. 5. Munro I.C., Harwood M., Hlywka J.J. i wsp.: Soy isoflavones: a safety review. Nutr. Rev. 2003, 61, 1. 6. Strauss L., Santti R., Saarinen N. i wsp.: Dietary phytoestrogens and their role in hormonally dependent disease. Toxicol. Lett. 1998, 102, 349. 7. Holder C.L., Churchwell M.I., Doerge D.R.: Quantification of soy isoflavones, genistein, daidzein, and conjugates in rat blood using LC/ES-MS. J. Agric. Food. Chem. 1999, 47, 3764. 8. Deorge D.R., Chang H.C., Churchwell M.I. i wsp.: Analysis of soy isoflavones conjugation in vitro and in human blood using liquid chromatography-mass spectrometry. Drug Metab. Dispos. 2000, 28, 298. 9. Cassidy A.: Physiological effects of phyto-oestrogens in relation to cancer and other human health risk. Proc. Nutr. Soc. 1996, 55, 399. 10. Chang H.C., Doerge D.R.: Dietary genistein inactivates rat thyroid peroxidase in vivo without an apparent hypothyroid effect. Toxicol. Appl. Pharmacol. 2000, 168, 244. 11. Halverson A.W., Zepplin M., Hart E.B.: Relation of iodine to the goitrogenic properties of soybeans. J. Nutr. 1949, 38, 115. 12. McCarrison R.: The goitrogenic action of soya-bean and ground-nut. Indian J. Med. Res. 1933, 21, 179. 13. Sharpless G.R., Pearson J., Prato G.S.: Production of goiter in rats with raw and with treated soybean flour. J. Nutr. 1939, 17, 545. 14. Wilgus H.S., Gassner F.X., Patton A.R. i wsp.: The goitrogenicity of soybeans. J. Nutr. 1941, 22, 43. 15. Block R.J., Mandl R.H.: The curative action of iodine on soybean goiter and the changes in the distribution of iodoamino acids in the serum and in thyroid gland digests. Arch. Biochem. Biophys. 1961, 93, 15. 16. Middlesworth L.: Thyroxine excretion, a possible cause of goiter. Endocrinol. 1957, 61, 570. 17. Kimura S., Suwa J., Ito M. i wsp.: Development of malignant goiter by defatted soybean with iodine-free diet in rats. Gann. 1976, 67, 763. 18. Ikeda T., Nishikawa A., Imazawa T. i wsp.: Dramatic synergism between soybean intake and iodine deficiency on the development of rat thyroid hyperplasia.Carcinogenesis 2000, 21, 707. 19. Ikeda T., Nishikawa A., Son H.Y. i wsp.: Synergistic effects of high-dose soybean intake with iodine deficiency, but not sulfadimethoxine or phenobarbital, on rat thyroid proliferation. Jpn. J. Cancer. Res. 2001, 92, 390. 20. Son H.Y., Nishikawa A., Ikeda T. i wsp: Lack of effect of soy isoflavone on thyroid hyperplasia in rats receiving an iodine-deficient diet. Jpn. J. Cancer. Res. 2001, 92, 103. 21. Son H.Y., Nikishawa A., Ikeda T. i wsp.: Lack of modifying effects of envirinmental estrogenic compounds on the development of thyroid proliferative lesions in male rats pretreated with N-bis(2-hydroxypropyl)nitrosamine (DHPN). Jpn. J. Cancer. Res. 2000, 91, 899. 22. Akiba Y., Jensen J.S., Barb C. i wsp.: Plasma estradiol, thyroid hormones and liver lipid content of laying hens fed different isocaloric diets. J. Nutr. 1982, 112, 229. 23. Akiba Y., Jensen J.S.: Temporal effects of change in diet composition on plasma estradiol and thyroxine concentrations and hepatic lipogenesis in laying hens. J. Nutr. 1983, 113, 2078. 24. Scholz-Ahrens K.E., Hagemeister H., Unshelm J. i wsp.: Response of hormones modulating plasma cholesterol to dietary casein or soy protein in minipigs. J. Nutr. 1990, 120, 1387. 25. Forsythe W.A.: Soy protein, thyroid regulation and cholesterol metabolism. J. Nutr. 1995, 125, 619. 26. White H.L., Freeman L.M., Mahony O. i wsp.: Effects of dietary soy on serum thyroid hormone concentrations in healthy adult cats. Am. J. Vet. Res. 2004, 65, 586. 27. Forsythe W.E.: Comparison of dietary casein or soy protein effects on plasma lipids and hormone concentration in the gerbil. J. Nutr. 1986, 116, 1165. 28. Xiao C.W., L´Abbe M.R., Gilani G.S. i wsp.: Papademetriou SA. Dietary soy protein isolate and isoflavones modulate hepatic thyroid hormone receptors in rats. J. Nutr. 2004, 134, 743. 29. Ali A.A., Velasequez M.T., Hansen C.T. i wsp.: Effects of soybean isoflavones, probiotics and their interactuions on lipid metabolism and endocrine system in an animal model of obesity and diabetes. J. Nutr. Biochem. 2004, 15, 583. 30. Lazar M.A.: Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr. Rev. 1993, 14, 184. 31. Huang W., Wood C., L´Abbe M.R. i wsp.: Soy protein isolate increases hepatic thyroid hormone receptor content and inhibits its binding to target genes in rats. J. Nutr. 2005, 135, 1631. 32. Beck R.N.: Soy flour and fecal thyroxine loss in rats. Endocrinology 1958, 62, 587. 33. Hydovitz J.D.: Occurence of goiter in an infant on a soy diet. N. Engl. J. Med. 1960, 262, 351. 34. Ripp J.A., Westbury N.Y.: Soybean-induced goiter. Am. J. Dis. Child. 1961, 106, 136. 35. Shepard T.H., Pyne G.E., Kirschvink J.F. i wsp.: Soybean goiter. N. Engl. J. Med. 1960, 262, 1099. 36. Van Wyk J.J., Arnold M.B., Wynn J. i wsp.: The effects of a soybean product on thyroid function in humans. Pediatrics 1959, 24, 752. 37. Pinchera A., MacGillivray M., Crawford J.D. I wsp.: Thyroid refractoriness in an athyreotic cretin fed soybean formula. N. Engl. J. Med. 1965, 273, 83. 38. Chorąży P.A., Himelhoch S., Hopwood N.J. i wsp.: Persistent hypothyroidism in an infant receiving a soy formula: case report and review of the literature. Pediatrics 1995, 96, 148. 39. Jabbar M.A., Larrea J., Shaw R.A.: Abnormal thyroid function tests in infants with congenital hypothyroidism: the influence of soy-based formula. J. Am. Coll. Nutr. 1997, 16, 280. 40. Conrad S.C., Chiu H., Silverman B.L.: Soy formula complicates management of congenital hypothyroidism. Arch. Dis. Child. 2004, 89, 37. 41. Fort P., Moses N., Fasano M., Goldberg T. i wsp.: Lifshitz F. Breast and soy-formula feedings in early infancy and the prevalence of autoimmune thyroid disease in children. J. Am. Coll. Nutr. 1990, 9, 164. 42. Doerge D.R., Sheehan D.M.: Goitrogenic and estrogenic activity of soy isoflavones. Environ Health Perspect. 2002, 110, 349. 43. Merrit R.J., Jenks B.H.: Safety of soy-based infant formulas containing isoflavones: the clinical evidence. J. Nutr. 2004, 134, 1220. 44. Milerova J., Cerovska J., Zamrazil V. i wsp.: Actual levels of soy phytoestrogens in children correlate with thyroid laboratory parameters. Clin. Chem. Lab. Med. 2006, 44, 171. 45. Ishizuki Y., Hirooka Y., Murata Y. i wsp.: The effects on thyroid gland of soybeans admistered experimentally in healthy subjects. Nippon Naibunpi Gakkai Zasshi 1991, 67, 622 (abstr.). 46. Duncan A.M., Merz B.E., Xu X. i wsp.: Soy isoflavones exert modest hormonal effects in premenopausal women. J. Clin. Endocrinol. Metab. 1999, 84, 192. 47. Duncan A.M., Underhill K.E.W., Xu X. i wsp.: Modest hormonal effects of soy isoflavones in postmenopausal women. J. Clin. Endocrinol. Metab. 1999, 84, 3479. 48. Persky V.W., Turyk M.E., Wang L. i wsp.: Effect of soy protein on endogenous hormones in postmenopausal women. Am. J. Clin. Nutr. 2002, 75, 145. 49. Bruce B., Messina M., Soiller G.A.: Isoflavone supplements do not affect thyroid function in iodine-replete postmenopausal women. J. Med. Food. 2003, 6, 309. 50. Setchell K.D.: Soy isoflavones – benefits and risks from nature´s selective estrogen receptor modulators (SERMs). J. Am. Coll. Nutr. 2001, 20, 354. 51. Dedecjus M., Słowińska-Klencka D., Klencki M. i wsp.: Receptory estrogenowe w nowotworach tarczycy. Endokrynol. Pol. 1999, 50, 401. 52. Lewy-Trenda I.: Estrogen and Progesterone Receptors in Neoplastic and Non-Neoplastic Thyroid Lesions. Pol. J. Pathol. 2002, 53, 67. 53. Horn-Ross P.L., Hoggatt K.J., Lee M.M.: Phytoestrogens and thyroid cancer risk: the San Francisco Bay Area thyroid cancer study. Cancer. Epidemiol. Biomarkers Prev. 2002, 11, 43. 54. Yin F., Giuliano A.E., Van Herle A.J.: Growth inhibitory effects of flavonoids in human thyroid cancer cell lines. Thyroid 1999, 9, 369. 55. Divi R.L., Chang H.C., Doerge D.R.: Anti-thyroid isoflavones from soybean: isolation, characterisation and mechanism of action. Biochem. Pharmcol. 1997, 54, 1087. 56. Krajcovicova-Kudlackova M., Buckova K., Klimes I. i wsp.: Iodine deficiency in vegetarians and vegans. Ann. Nutr. Metab. 2003, 47, 183. 57. Gietka-Czernel M, Niedoczynność tarczycy. W: Rozpoznawanie i leczenie chorób tarczycy (red. M. Gietka-Czernel, H. Jastrzębska).: Ośr. Inf. Nauk. Polfa, Warszawa 2002, 132.